Yisheng Biopharma to Present at BioPharma Asia Convention 2017 in Singapore

BEIJING, March 15, 2017 /PRNewswire/ 

Yisheng Biopharma Co., Ltd. (“Yisheng Biopharma”), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immuno-therapeutic products and vaccines, today announced that the company will present at annual BioPharma Asia Convention 2017 at Suntec Convention Center, Singapore. The presentation is scheduled for 12:40 PM local time on March 22, 2017.

The management of Yisheng Biopharma will provide its business update on clinical progress of immuno-oncology therapeutics, vaccine products as well as commercialization strategies in Asia, USA and Europe.

About Yisheng Biopharma Co., Ltd.

Yisheng Biopharma Co., Ltd. is a biopharmaceutical company headquartered in Beijing, China, focusing on the research, development, manufacturing and sales and marketing of immunological and vaccine products, with approximately 1000 employees in China, USA and Singapore.